- Report
- July 2025
- 175 Pages
Global
From €3977EUR$4,490USD£3,446GBP
- Report
- March 2025
- 150 Pages
Global
From €2879EUR$3,250USD£2,495GBP
€4296EUR$4,850USD£3,723GBP
- Report
- May 2025
- 105 Pages
Global
From €4208EUR$4,750USD£3,646GBP
- Report
- January 2025
- 300 Pages
Global
From €4385EUR$4,950USD£3,799GBP
- Report
- November 2024
- 239 Pages
Global
From €3698EUR$4,175USD£3,205GBP
- Report
- May 2025
- 186 Pages
Global
From €3140EUR$3,545USD£2,721GBP
€3489EUR$3,939USD£3,023GBP
- Report
- May 2025
- 189 Pages
Global
From €3140EUR$3,545USD£2,721GBP
€3489EUR$3,939USD£3,023GBP
- Report
- May 2025
- 186 Pages
Global
From €3140EUR$3,545USD£2,721GBP
€3489EUR$3,939USD£3,023GBP
- Report
- March 2025
- 142 Pages
Global
From €2657EUR$2,999USD£2,302GBP
- Report
- February 2025
- 200 Pages
Global
From €3977EUR$4,490USD£3,446GBP
- Report
- March 2025
- 150 Pages
Global
From €2879EUR$3,250USD£2,495GBP
€4296EUR$4,850USD£3,723GBP
- Report
- April 2025
- 150 Pages
Global
From €2879EUR$3,250USD£2,495GBP
€4296EUR$4,850USD£3,723GBP
- Report
- July 2025
- 273 Pages
Global
From €5182EUR$5,850USD£4,490GBP
- Report
- July 2025
- 281 Pages
Global
From €5182EUR$5,850USD£4,490GBP
- Report
- July 2025
- 481 Pages
Global
From €5182EUR$5,850USD£4,490GBP
- Report
- July 2025
- 372 Pages
Global
From €5182EUR$5,850USD£4,490GBP
- Report
- July 2025
- 573 Pages
Global
From €5182EUR$5,850USD£4,490GBP
- Report
- July 2025
- 276 Pages
Global
From €5182EUR$5,850USD£4,490GBP
- Report
- July 2025
- 576 Pages
Global
From €5182EUR$5,850USD£4,490GBP
- Report
- April 2025
- 144 Pages
Global
From €2657EUR$2,999USD£2,302GBP

The Preventive Vaccine market is a subset of the Vaccines market, which is focused on the development and distribution of vaccines to prevent the spread of infectious diseases. Vaccines are typically administered to healthy individuals to protect them from contracting a disease, and are often used in public health initiatives to reduce the spread of disease. Vaccines are typically developed through a combination of research and clinical trials, and are then approved by regulatory bodies before they can be distributed.
The Preventive Vaccine market is highly competitive, with a range of companies involved in the development, production, and distribution of vaccines. Companies in the market include Merck & Co., GlaxoSmithKline, Pfizer, Sanofi, Johnson & Johnson, and Novartis. Show Less Read more